Page 2 - Shenzhen Kangtai News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FILE PHOTO Metro Manila (CNN Philippines, May 16) The country received three new COVID-19 vaccine clinical trial applications, Science and Technology Undersecretary Rowena Guevara said Tuesday. The vaccine developers that applied to conduct Phase 3 trials were the West China Hospital and Sichuan University, Shenzhen Kangtai Biological Products Co., and Eubiologics Co. Ltd., Guevara said in a briefing. The undersecretary said evaluation of the applications submitted by the West China Hospital and Sichuan University, as well as Shenzhen Kangtai is underway while Eubiologics is still “completing some requirements.” Meanwhile, the Department of Science Technology is also waiting the World Health Organization s release of its final protocol and list of COVID-19 shots for its Solidarity vaccine trials in the country. Guevara said WHO is expected to submit the documents “by the end of the month.”

Metro manilaPhilippines generalSinovac biotechDepartment of science technologyDrug administrationWorld health organizationSichuan universityTechnology undersecretary rowena guevaraShenzhen kangtai biological products coEubiologics coWest china hospitalShenzhen kangtaiScience technologyClover biopharmaceuticalsClover biopharmaceuticalமெட்ரோ மணிலா